nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—CYP3A4—type 2 diabetes mellitus	0.146	1	CbGaD
Zalcitabine—SLC22A7—Glyburide—type 2 diabetes mellitus	0.0412	0.0742	CbGbCtD
Zalcitabine—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0342	0.0617	CbGbCtD
Zalcitabine—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0305	0.055	CbGbCtD
Zalcitabine—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0259	0.0467	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0236	0.0426	CbGbCtD
Zalcitabine—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0236	0.0426	CbGbCtD
Zalcitabine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0217	0.0391	CbGbCtD
Zalcitabine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0199	0.0358	CbGbCtD
Zalcitabine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0185	0.0333	CbGbCtD
Zalcitabine—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0177	0.032	CbGbCtD
Zalcitabine—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0175	0.0316	CbGbCtD
Zalcitabine—SLC22A6—Losartan—type 2 diabetes mellitus	0.016	0.0289	CbGbCtD
Zalcitabine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0157	0.0283	CbGbCtD
Zalcitabine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0157	0.0283	CbGbCtD
Zalcitabine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0145	0.0261	CbGbCtD
Zalcitabine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0144	0.0259	CbGbCtD
Zalcitabine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0142	0.0255	CbGbCtD
Zalcitabine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.014	0.0252	CbGbCtD
Zalcitabine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0132	0.0239	CbGbCtD
Zalcitabine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0128	0.0231	CbGbCtD
Zalcitabine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0126	0.0228	CbGbCtD
Zalcitabine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0119	0.0215	CbGbCtD
Zalcitabine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0115	0.0208	CbGbCtD
Zalcitabine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0114	0.0206	CbGbCtD
Zalcitabine—CYP3A5—Losartan—type 2 diabetes mellitus	0.011	0.0198	CbGbCtD
Zalcitabine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0109	0.0196	CbGbCtD
Zalcitabine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0104	0.0188	CbGbCtD
Zalcitabine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0101	0.0182	CbGbCtD
Zalcitabine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00913	0.0165	CbGbCtD
Zalcitabine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00803	0.0145	CbGbCtD
Zalcitabine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00735	0.0133	CbGbCtD
Zalcitabine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00692	0.0125	CbGbCtD
Zalcitabine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00663	0.012	CbGbCtD
Zalcitabine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00663	0.012	CbGbCtD
Zalcitabine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00627	0.0113	CbGbCtD
Zalcitabine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00467	0.00843	CbGbCtD
Zalcitabine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00427	0.00771	CbGbCtD
Zalcitabine—Decitabine—DNMT1—type 2 diabetes mellitus	0.00179	0.722	CrCbGaD
Zalcitabine—SLC29A2—cardiovascular system—type 2 diabetes mellitus	0.00137	0.0562	CbGeAlD
Zalcitabine—CYP3A43—liver—type 2 diabetes mellitus	0.00131	0.0539	CbGeAlD
Zalcitabine—SLC29A2—adipose tissue—type 2 diabetes mellitus	0.00121	0.0496	CbGeAlD
Zalcitabine—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000945	0.0388	CbGeAlD
Zalcitabine—SLC29A1—islet of Langerhans—type 2 diabetes mellitus	0.000938	0.0385	CbGeAlD
Zalcitabine—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000903	0.0371	CbGeAlD
Zalcitabine—DCK—islet of Langerhans—type 2 diabetes mellitus	0.000897	0.0368	CbGeAlD
Zalcitabine—SLC22A7—kidney—type 2 diabetes mellitus	0.000861	0.0353	CbGeAlD
Zalcitabine—SLC29A2—liver—type 2 diabetes mellitus	0.000847	0.0348	CbGeAlD
Zalcitabine—SLC22A7—cortex of kidney—type 2 diabetes mellitus	0.000838	0.0344	CbGeAlD
Zalcitabine—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000809	0.0332	CbGeAlD
Zalcitabine—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000773	0.0317	CbGeAlD
Zalcitabine—DCK—retina—type 2 diabetes mellitus	0.000766	0.0315	CbGeAlD
Zalcitabine—DCK—nephron tubule—type 2 diabetes mellitus	0.000722	0.0296	CbGeAlD
Zalcitabine—SLC29A1—cardiovascular system—type 2 diabetes mellitus	0.000679	0.0279	CbGeAlD
Zalcitabine—SLC29A1—kidney—type 2 diabetes mellitus	0.000664	0.0273	CbGeAlD
Zalcitabine—SLC29A1—pancreas—type 2 diabetes mellitus	0.00066	0.0271	CbGeAlD
Zalcitabine—SLC29A1—cortex of kidney—type 2 diabetes mellitus	0.000647	0.0265	CbGeAlD
Zalcitabine—DCK—pancreas—type 2 diabetes mellitus	0.00063	0.0259	CbGeAlD
Zalcitabine—DCK—cortex of kidney—type 2 diabetes mellitus	0.000618	0.0254	CbGeAlD
Zalcitabine—SLC29A1—adipose tissue—type 2 diabetes mellitus	0.000599	0.0246	CbGeAlD
Zalcitabine—CYP3A7—liver—type 2 diabetes mellitus	0.00059	0.0242	CbGeAlD
Zalcitabine—DCK—adipose tissue—type 2 diabetes mellitus	0.000572	0.0235	CbGeAlD
Zalcitabine—SLC22A7—liver—type 2 diabetes mellitus	0.000544	0.0223	CbGeAlD
Zalcitabine—Lamivudine—ABCC2—type 2 diabetes mellitus	0.000517	0.209	CrCbGaD
Zalcitabine—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000502	0.0206	CbGeAlD
Zalcitabine—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000464	0.0191	CbGeAlD
Zalcitabine—SLC29A1—liver—type 2 diabetes mellitus	0.00042	0.0172	CbGeAlD
Zalcitabine—DCK—liver—type 2 diabetes mellitus	0.000401	0.0165	CbGeAlD
Zalcitabine—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000374	0.0153	CbGeAlD
Zalcitabine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.00033	0.0136	CbGeAlD
Zalcitabine—CYP3A5—kidney—type 2 diabetes mellitus	0.000329	0.0135	CbGeAlD
Zalcitabine—CYP3A5—pancreas—type 2 diabetes mellitus	0.000326	0.0134	CbGeAlD
Zalcitabine—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.00032	0.0131	CbGeAlD
Zalcitabine—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000296	0.0122	CbGeAlD
Zalcitabine—CYP3A4—kidney—type 2 diabetes mellitus	0.000247	0.0101	CbGeAlD
Zalcitabine—CYP2D6—kidney—type 2 diabetes mellitus	0.000243	0.00996	CbGeAlD
Zalcitabine—CYP3A5—liver—type 2 diabetes mellitus	0.000208	0.00852	CbGeAlD
Zalcitabine—CYP2C9—liver—type 2 diabetes mellitus	0.000204	0.00839	CbGeAlD
Zalcitabine—Cytarabine—CYP3A4—type 2 diabetes mellitus	0.000171	0.0692	CrCbGaD
Zalcitabine—CYP3A4—liver—type 2 diabetes mellitus	0.000156	0.0064	CbGeAlD
Zalcitabine—CYP2D6—liver—type 2 diabetes mellitus	0.000153	0.00629	CbGeAlD
Zalcitabine—Anorexia—Valsartan—type 2 diabetes mellitus	8.13e-05	0.000404	CcSEcCtD
Zalcitabine—Muscle spasms—Losartan—type 2 diabetes mellitus	8.13e-05	0.000404	CcSEcCtD
Zalcitabine—Asthenia—Bromocriptine—type 2 diabetes mellitus	8.12e-05	0.000403	CcSEcCtD
Zalcitabine—Myalgia—Metformin—type 2 diabetes mellitus	8.1e-05	0.000402	CcSEcCtD
Zalcitabine—Malaise—Irbesartan—type 2 diabetes mellitus	8.1e-05	0.000402	CcSEcCtD
Zalcitabine—Vertigo—Irbesartan—type 2 diabetes mellitus	8.07e-05	0.000401	CcSEcCtD
Zalcitabine—Headache—Pioglitazone—type 2 diabetes mellitus	8.06e-05	0.0004	CcSEcCtD
Zalcitabine—Syncope—Irbesartan—type 2 diabetes mellitus	8.06e-05	0.0004	CcSEcCtD
Zalcitabine—Leukopenia—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.000399	CcSEcCtD
Zalcitabine—Visual impairment—Ramipril—type 2 diabetes mellitus	8.03e-05	0.000398	CcSEcCtD
Zalcitabine—Discomfort—Metformin—type 2 diabetes mellitus	8.01e-05	0.000398	CcSEcCtD
Zalcitabine—Fatigue—Gliclazide—type 2 diabetes mellitus	8.01e-05	0.000398	CcSEcCtD
Zalcitabine—Vomiting—Glimepiride—type 2 diabetes mellitus	7.97e-05	0.000396	CcSEcCtD
Zalcitabine—Vision blurred—Losartan—type 2 diabetes mellitus	7.97e-05	0.000396	CcSEcCtD
Zalcitabine—Vomiting—Sitagliptin—type 2 diabetes mellitus	7.95e-05	0.000395	CcSEcCtD
Zalcitabine—Pain—Gliclazide—type 2 diabetes mellitus	7.94e-05	0.000394	CcSEcCtD
Zalcitabine—Tremor—Losartan—type 2 diabetes mellitus	7.92e-05	0.000393	CcSEcCtD
Zalcitabine—Rash—Glimepiride—type 2 diabetes mellitus	7.91e-05	0.000393	CcSEcCtD
Zalcitabine—Dermatitis—Glimepiride—type 2 diabetes mellitus	7.9e-05	0.000392	CcSEcCtD
Zalcitabine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	7.9e-05	0.000392	CcSEcCtD
Zalcitabine—Rash—Sitagliptin—type 2 diabetes mellitus	7.88e-05	0.000391	CcSEcCtD
Zalcitabine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	7.87e-05	0.000391	CcSEcCtD
Zalcitabine—Headache—Glimepiride—type 2 diabetes mellitus	7.86e-05	0.00039	CcSEcCtD
Zalcitabine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	7.84e-05	0.000389	CcSEcCtD
Zalcitabine—Cough—Irbesartan—type 2 diabetes mellitus	7.84e-05	0.000389	CcSEcCtD
Zalcitabine—Headache—Sitagliptin—type 2 diabetes mellitus	7.83e-05	0.000389	CcSEcCtD
Zalcitabine—Anaemia—Losartan—type 2 diabetes mellitus	7.81e-05	0.000388	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	7.77e-05	0.000386	CcSEcCtD
Zalcitabine—Agitation—Losartan—type 2 diabetes mellitus	7.77e-05	0.000386	CcSEcCtD
Zalcitabine—Oedema—Metformin—type 2 diabetes mellitus	7.77e-05	0.000386	CcSEcCtD
Zalcitabine—Tinnitus—Ramipril—type 2 diabetes mellitus	7.76e-05	0.000386	CcSEcCtD
Zalcitabine—Hypertension—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.000385	CcSEcCtD
Zalcitabine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	7.74e-05	0.000384	CcSEcCtD
Zalcitabine—Flushing—Ramipril—type 2 diabetes mellitus	7.73e-05	0.000384	CcSEcCtD
Zalcitabine—Infection—Metformin—type 2 diabetes mellitus	7.72e-05	0.000383	CcSEcCtD
Zalcitabine—Insomnia—Valsartan—type 2 diabetes mellitus	7.72e-05	0.000383	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.68e-05	0.000381	CcSEcCtD
Zalcitabine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.65e-05	0.00038	CcSEcCtD
Zalcitabine—Myalgia—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.00038	CcSEcCtD
Zalcitabine—Arthralgia—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.00038	CcSEcCtD
Zalcitabine—Shock—Metformin—type 2 diabetes mellitus	7.64e-05	0.00038	CcSEcCtD
Zalcitabine—Insomnia—Orlistat—type 2 diabetes mellitus	7.62e-05	0.000379	CcSEcCtD
Zalcitabine—Malaise—Losartan—type 2 diabetes mellitus	7.62e-05	0.000379	CcSEcCtD
Zalcitabine—Anxiety—Irbesartan—type 2 diabetes mellitus	7.62e-05	0.000378	CcSEcCtD
Zalcitabine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.62e-05	0.000378	CcSEcCtD
Zalcitabine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.61e-05	0.000378	CcSEcCtD
Zalcitabine—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.61e-05	0.000378	CcSEcCtD
Zalcitabine—Vertigo—Losartan—type 2 diabetes mellitus	7.6e-05	0.000377	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.59e-05	0.000377	CcSEcCtD
Zalcitabine—Somnolence—Valsartan—type 2 diabetes mellitus	7.58e-05	0.000377	CcSEcCtD
Zalcitabine—Syncope—Losartan—type 2 diabetes mellitus	7.58e-05	0.000376	CcSEcCtD
Zalcitabine—Leukopenia—Losartan—type 2 diabetes mellitus	7.57e-05	0.000376	CcSEcCtD
Zalcitabine—Discomfort—Irbesartan—type 2 diabetes mellitus	7.56e-05	0.000375	CcSEcCtD
Zalcitabine—Skin disorder—Metformin—type 2 diabetes mellitus	7.55e-05	0.000375	CcSEcCtD
Zalcitabine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.51e-05	0.000373	CcSEcCtD
Zalcitabine—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.51e-05	0.000373	CcSEcCtD
Zalcitabine—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.48e-05	0.000371	CcSEcCtD
Zalcitabine—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.48e-05	0.000371	CcSEcCtD
Zalcitabine—Palpitations—Losartan—type 2 diabetes mellitus	7.47e-05	0.000371	CcSEcCtD
Zalcitabine—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.44e-05	0.000369	CcSEcCtD
Zalcitabine—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.43e-05	0.000369	CcSEcCtD
Zalcitabine—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.42e-05	0.000368	CcSEcCtD
Zalcitabine—Asthenia—Glyburide—type 2 diabetes mellitus	7.42e-05	0.000368	CcSEcCtD
Zalcitabine—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.42e-05	0.000368	CcSEcCtD
Zalcitabine—Anorexia—Metformin—type 2 diabetes mellitus	7.41e-05	0.000368	CcSEcCtD
Zalcitabine—Cough—Losartan—type 2 diabetes mellitus	7.38e-05	0.000366	CcSEcCtD
Zalcitabine—Urticaria—Gliclazide—type 2 diabetes mellitus	7.38e-05	0.000366	CcSEcCtD
Zalcitabine—Alopecia—Ramipril—type 2 diabetes mellitus	7.36e-05	0.000365	CcSEcCtD
Zalcitabine—Fatigue—Valsartan—type 2 diabetes mellitus	7.36e-05	0.000365	CcSEcCtD
Zalcitabine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.34e-05	0.000364	CcSEcCtD
Zalcitabine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.34e-05	0.000364	CcSEcCtD
Zalcitabine—Oedema—Irbesartan—type 2 diabetes mellitus	7.33e-05	0.000364	CcSEcCtD
Zalcitabine—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.33e-05	0.000364	CcSEcCtD
Zalcitabine—Pruritus—Glyburide—type 2 diabetes mellitus	7.32e-05	0.000363	CcSEcCtD
Zalcitabine—Infection—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.000362	CcSEcCtD
Zalcitabine—Fatigue—Orlistat—type 2 diabetes mellitus	7.27e-05	0.000361	CcSEcCtD
Zalcitabine—Shock—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.000358	CcSEcCtD
Zalcitabine—Pain—Orlistat—type 2 diabetes mellitus	7.21e-05	0.000358	CcSEcCtD
Zalcitabine—Myalgia—Losartan—type 2 diabetes mellitus	7.2e-05	0.000357	CcSEcCtD
Zalcitabine—Arthralgia—Losartan—type 2 diabetes mellitus	7.2e-05	0.000357	CcSEcCtD
Zalcitabine—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.19e-05	0.000357	CcSEcCtD
Zalcitabine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.18e-05	0.000356	CcSEcCtD
Zalcitabine—Anxiety—Losartan—type 2 diabetes mellitus	7.17e-05	0.000356	CcSEcCtD
Zalcitabine—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.16e-05	0.000355	CcSEcCtD
Zalcitabine—Rash—Bromocriptine—type 2 diabetes mellitus	7.13e-05	0.000354	CcSEcCtD
Zalcitabine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.13e-05	0.000354	CcSEcCtD
Zalcitabine—Skin disorder—Irbesartan—type 2 diabetes mellitus	7.12e-05	0.000354	CcSEcCtD
Zalcitabine—Tension—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000353	CcSEcCtD
Zalcitabine—Discomfort—Losartan—type 2 diabetes mellitus	7.11e-05	0.000353	CcSEcCtD
Zalcitabine—Dysgeusia—Ramipril—type 2 diabetes mellitus	7.1e-05	0.000352	CcSEcCtD
Zalcitabine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.09e-05	0.000352	CcSEcCtD
Zalcitabine—Headache—Bromocriptine—type 2 diabetes mellitus	7.09e-05	0.000352	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.08e-05	0.000351	CcSEcCtD
Zalcitabine—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.08e-05	0.000351	CcSEcCtD
Zalcitabine—Nervousness—Ramipril—type 2 diabetes mellitus	7.04e-05	0.00035	CcSEcCtD
Zalcitabine—Dry mouth—Losartan—type 2 diabetes mellitus	7.04e-05	0.00035	CcSEcCtD
Zalcitabine—Anorexia—Irbesartan—type 2 diabetes mellitus	6.99e-05	0.000347	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.98e-05	0.000346	CcSEcCtD
Zalcitabine—Muscle spasms—Ramipril—type 2 diabetes mellitus	6.97e-05	0.000346	CcSEcCtD
Zalcitabine—Confusional state—Losartan—type 2 diabetes mellitus	6.96e-05	0.000345	CcSEcCtD
Zalcitabine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.95e-05	0.000345	CcSEcCtD
Zalcitabine—Dyspnoea—Metformin—type 2 diabetes mellitus	6.93e-05	0.000344	CcSEcCtD
Zalcitabine—Somnolence—Metformin—type 2 diabetes mellitus	6.91e-05	0.000343	CcSEcCtD
Zalcitabine—Oedema—Losartan—type 2 diabetes mellitus	6.9e-05	0.000343	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.89e-05	0.000342	CcSEcCtD
Zalcitabine—Infection—Losartan—type 2 diabetes mellitus	6.85e-05	0.00034	CcSEcCtD
Zalcitabine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.84e-05	0.00034	CcSEcCtD
Zalcitabine—Dyspepsia—Metformin—type 2 diabetes mellitus	6.84e-05	0.00034	CcSEcCtD
Zalcitabine—Tremor—Ramipril—type 2 diabetes mellitus	6.79e-05	0.000337	CcSEcCtD
Zalcitabine—Shock—Losartan—type 2 diabetes mellitus	6.79e-05	0.000337	CcSEcCtD
Zalcitabine—Urticaria—Valsartan—type 2 diabetes mellitus	6.78e-05	0.000337	CcSEcCtD
Zalcitabine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.76e-05	0.000335	CcSEcCtD
Zalcitabine—Decreased appetite—Metformin—type 2 diabetes mellitus	6.75e-05	0.000335	CcSEcCtD
Zalcitabine—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.74e-05	0.000335	CcSEcCtD
Zalcitabine—Tachycardia—Losartan—type 2 diabetes mellitus	6.73e-05	0.000334	CcSEcCtD
Zalcitabine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.73e-05	0.000334	CcSEcCtD
Zalcitabine—Fatigue—Metformin—type 2 diabetes mellitus	6.7e-05	0.000333	CcSEcCtD
Zalcitabine—Urticaria—Orlistat—type 2 diabetes mellitus	6.7e-05	0.000333	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000332	CcSEcCtD
Zalcitabine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.67e-05	0.000331	CcSEcCtD
Zalcitabine—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.66e-05	0.000331	CcSEcCtD
Zalcitabine—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.66e-05	0.000331	CcSEcCtD
Zalcitabine—Asthenia—Gliclazide—type 2 diabetes mellitus	6.66e-05	0.000331	CcSEcCtD
Zalcitabine—Agitation—Ramipril—type 2 diabetes mellitus	6.66e-05	0.000331	CcSEcCtD
Zalcitabine—Anorexia—Losartan—type 2 diabetes mellitus	6.58e-05	0.000327	CcSEcCtD
Zalcitabine—Vomiting—Glyburide—type 2 diabetes mellitus	6.58e-05	0.000326	CcSEcCtD
Zalcitabine—Pruritus—Gliclazide—type 2 diabetes mellitus	6.57e-05	0.000326	CcSEcCtD
Zalcitabine—Malaise—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000325	CcSEcCtD
Zalcitabine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.54e-05	0.000325	CcSEcCtD
Zalcitabine—Rash—Glyburide—type 2 diabetes mellitus	6.52e-05	0.000324	CcSEcCtD
Zalcitabine—Somnolence—Irbesartan—type 2 diabetes mellitus	6.52e-05	0.000324	CcSEcCtD
Zalcitabine—Dermatitis—Glyburide—type 2 diabetes mellitus	6.51e-05	0.000323	CcSEcCtD
Zalcitabine—Vertigo—Ramipril—type 2 diabetes mellitus	6.51e-05	0.000323	CcSEcCtD
Zalcitabine—Syncope—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000323	CcSEcCtD
Zalcitabine—Leukopenia—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000322	CcSEcCtD
Zalcitabine—Headache—Glyburide—type 2 diabetes mellitus	6.48e-05	0.000322	CcSEcCtD
Zalcitabine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.45e-05	0.00032	CcSEcCtD
Zalcitabine—Palpitations—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000318	CcSEcCtD
Zalcitabine—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.4e-05	0.000318	CcSEcCtD
Zalcitabine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.37e-05	0.000316	CcSEcCtD
Zalcitabine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000316	CcSEcCtD
Zalcitabine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.35e-05	0.000315	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.35e-05	0.000315	CcSEcCtD
Zalcitabine—Cough—Ramipril—type 2 diabetes mellitus	6.33e-05	0.000314	CcSEcCtD
Zalcitabine—Fatigue—Irbesartan—type 2 diabetes mellitus	6.32e-05	0.000314	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.29e-05	0.000312	CcSEcCtD
Zalcitabine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.29e-05	0.000312	CcSEcCtD
Zalcitabine—Convulsion—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000312	CcSEcCtD
Zalcitabine—Pain—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.000311	CcSEcCtD
Zalcitabine—Insomnia—Losartan—type 2 diabetes mellitus	6.24e-05	0.00031	CcSEcCtD
Zalcitabine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.21e-05	0.000308	CcSEcCtD
Zalcitabine—Urticaria—Metformin—type 2 diabetes mellitus	6.17e-05	0.000306	CcSEcCtD
Zalcitabine—Arthralgia—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000306	CcSEcCtD
Zalcitabine—Myalgia—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000306	CcSEcCtD
Zalcitabine—Dyspnoea—Losartan—type 2 diabetes mellitus	6.15e-05	0.000305	CcSEcCtD
Zalcitabine—Anxiety—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000305	CcSEcCtD
Zalcitabine—Abdominal pain—Metformin—type 2 diabetes mellitus	6.14e-05	0.000305	CcSEcCtD
Zalcitabine—Dizziness—Gliclazide—type 2 diabetes mellitus	6.14e-05	0.000305	CcSEcCtD
Zalcitabine—Somnolence—Losartan—type 2 diabetes mellitus	6.13e-05	0.000305	CcSEcCtD
Zalcitabine—Asthenia—Valsartan—type 2 diabetes mellitus	6.12e-05	0.000304	CcSEcCtD
Zalcitabine—Discomfort—Ramipril—type 2 diabetes mellitus	6.1e-05	0.000303	CcSEcCtD
Zalcitabine—Dyspepsia—Losartan—type 2 diabetes mellitus	6.07e-05	0.000302	CcSEcCtD
Zalcitabine—Asthenia—Orlistat—type 2 diabetes mellitus	6.05e-05	0.0003	CcSEcCtD
Zalcitabine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.04e-05	0.0003	CcSEcCtD
Zalcitabine—Pruritus—Valsartan—type 2 diabetes mellitus	6.04e-05	0.0003	CcSEcCtD
Zalcitabine—Dry mouth—Ramipril—type 2 diabetes mellitus	6.04e-05	0.0003	CcSEcCtD
Zalcitabine—Decreased appetite—Losartan—type 2 diabetes mellitus	6e-05	0.000298	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6e-05	0.000298	CcSEcCtD
Zalcitabine—Confusional state—Ramipril—type 2 diabetes mellitus	5.97e-05	0.000296	CcSEcCtD
Zalcitabine—Pruritus—Orlistat—type 2 diabetes mellitus	5.96e-05	0.000296	CcSEcCtD
Zalcitabine—Fatigue—Losartan—type 2 diabetes mellitus	5.95e-05	0.000295	CcSEcCtD
Zalcitabine—Oedema—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000294	CcSEcCtD
Zalcitabine—Vomiting—Gliclazide—type 2 diabetes mellitus	5.9e-05	0.000293	CcSEcCtD
Zalcitabine—Pain—Losartan—type 2 diabetes mellitus	5.9e-05	0.000293	CcSEcCtD
Zalcitabine—Rash—Gliclazide—type 2 diabetes mellitus	5.85e-05	0.000291	CcSEcCtD
Zalcitabine—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.85e-05	0.00029	CcSEcCtD
Zalcitabine—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.84e-05	0.00029	CcSEcCtD
Zalcitabine—Urticaria—Irbesartan—type 2 diabetes mellitus	5.82e-05	0.000289	CcSEcCtD
Zalcitabine—Shock—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000289	CcSEcCtD
Zalcitabine—Headache—Gliclazide—type 2 diabetes mellitus	5.82e-05	0.000289	CcSEcCtD
Zalcitabine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.8e-05	0.000288	CcSEcCtD
Zalcitabine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.8e-05	0.000288	CcSEcCtD
Zalcitabine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.79e-05	0.000288	CcSEcCtD
Zalcitabine—Tachycardia—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000287	CcSEcCtD
Zalcitabine—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.77e-05	0.000286	CcSEcCtD
Zalcitabine—Skin disorder—Ramipril—type 2 diabetes mellitus	5.75e-05	0.000285	CcSEcCtD
Zalcitabine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.72e-05	0.000284	CcSEcCtD
Zalcitabine—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.69e-05	0.000282	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.64e-05	0.00028	CcSEcCtD
Zalcitabine—Dizziness—Valsartan—type 2 diabetes mellitus	5.64e-05	0.00028	CcSEcCtD
Zalcitabine—Anorexia—Ramipril—type 2 diabetes mellitus	5.64e-05	0.00028	CcSEcCtD
Zalcitabine—Dizziness—Orlistat—type 2 diabetes mellitus	5.57e-05	0.000277	CcSEcCtD
Zalcitabine—Asthenia—Metformin—type 2 diabetes mellitus	5.57e-05	0.000277	CcSEcCtD
Zalcitabine—Pruritus—Metformin—type 2 diabetes mellitus	5.5e-05	0.000273	CcSEcCtD
Zalcitabine—Urticaria—Losartan—type 2 diabetes mellitus	5.48e-05	0.000272	CcSEcCtD
Zalcitabine—Abdominal pain—Losartan—type 2 diabetes mellitus	5.45e-05	0.000271	CcSEcCtD
Zalcitabine—Body temperature increased—Losartan—type 2 diabetes mellitus	5.45e-05	0.000271	CcSEcCtD
Zalcitabine—Vomiting—Valsartan—type 2 diabetes mellitus	5.42e-05	0.000269	CcSEcCtD
Zalcitabine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.4e-05	0.000268	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000268	CcSEcCtD
Zalcitabine—Rash—Valsartan—type 2 diabetes mellitus	5.38e-05	0.000267	CcSEcCtD
Zalcitabine—Dermatitis—Valsartan—type 2 diabetes mellitus	5.37e-05	0.000267	CcSEcCtD
Zalcitabine—Vomiting—Orlistat—type 2 diabetes mellitus	5.36e-05	0.000266	CcSEcCtD
Zalcitabine—Insomnia—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000266	CcSEcCtD
Zalcitabine—Headache—Valsartan—type 2 diabetes mellitus	5.34e-05	0.000265	CcSEcCtD
Zalcitabine—Diarrhoea—Metformin—type 2 diabetes mellitus	5.32e-05	0.000264	CcSEcCtD
Zalcitabine—Rash—Orlistat—type 2 diabetes mellitus	5.32e-05	0.000264	CcSEcCtD
Zalcitabine—Dermatitis—Orlistat—type 2 diabetes mellitus	5.31e-05	0.000264	CcSEcCtD
Zalcitabine—Headache—Orlistat—type 2 diabetes mellitus	5.28e-05	0.000262	CcSEcCtD
Zalcitabine—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.27e-05	0.000262	CcSEcCtD
Zalcitabine—Asthenia—Irbesartan—type 2 diabetes mellitus	5.26e-05	0.000261	CcSEcCtD
Zalcitabine—Somnolence—Ramipril—type 2 diabetes mellitus	5.26e-05	0.000261	CcSEcCtD
Zalcitabine—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000259	CcSEcCtD
Zalcitabine—Pruritus—Irbesartan—type 2 diabetes mellitus	5.19e-05	0.000258	CcSEcCtD
Zalcitabine—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000255	CcSEcCtD
Zalcitabine—Dizziness—Metformin—type 2 diabetes mellitus	5.14e-05	0.000255	CcSEcCtD
Zalcitabine—Fatigue—Ramipril—type 2 diabetes mellitus	5.1e-05	0.000253	CcSEcCtD
Zalcitabine—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.08e-05	0.000252	CcSEcCtD
Zalcitabine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.02e-05	0.000249	CcSEcCtD
Zalcitabine—Asthenia—Losartan—type 2 diabetes mellitus	4.95e-05	0.000246	CcSEcCtD
Zalcitabine—Vomiting—Metformin—type 2 diabetes mellitus	4.94e-05	0.000245	CcSEcCtD
Zalcitabine—Rash—Metformin—type 2 diabetes mellitus	4.9e-05	0.000243	CcSEcCtD
Zalcitabine—Dermatitis—Metformin—type 2 diabetes mellitus	4.89e-05	0.000243	CcSEcCtD
Zalcitabine—Pruritus—Losartan—type 2 diabetes mellitus	4.88e-05	0.000242	CcSEcCtD
Zalcitabine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.88e-05	0.000242	CcSEcCtD
Zalcitabine—Headache—Metformin—type 2 diabetes mellitus	4.87e-05	0.000242	CcSEcCtD
Zalcitabine—Dizziness—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.000241	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.84e-05	0.00024	CcSEcCtD
Zalcitabine—Diarrhoea—Losartan—type 2 diabetes mellitus	4.72e-05	0.000234	CcSEcCtD
Zalcitabine—Urticaria—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000233	CcSEcCtD
Zalcitabine—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.68e-05	0.000232	CcSEcCtD
Zalcitabine—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.68e-05	0.000232	CcSEcCtD
Zalcitabine—Vomiting—Irbesartan—type 2 diabetes mellitus	4.66e-05	0.000231	CcSEcCtD
Zalcitabine—Rash—Irbesartan—type 2 diabetes mellitus	4.62e-05	0.00023	CcSEcCtD
Zalcitabine—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.62e-05	0.000229	CcSEcCtD
Zalcitabine—Headache—Irbesartan—type 2 diabetes mellitus	4.59e-05	0.000228	CcSEcCtD
Zalcitabine—Dizziness—Losartan—type 2 diabetes mellitus	4.56e-05	0.000227	CcSEcCtD
Zalcitabine—Vomiting—Losartan—type 2 diabetes mellitus	4.39e-05	0.000218	CcSEcCtD
Zalcitabine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000216	CcSEcCtD
Zalcitabine—Rash—Losartan—type 2 diabetes mellitus	4.35e-05	0.000216	CcSEcCtD
Zalcitabine—Dermatitis—Losartan—type 2 diabetes mellitus	4.35e-05	0.000216	CcSEcCtD
Zalcitabine—Headache—Losartan—type 2 diabetes mellitus	4.32e-05	0.000215	CcSEcCtD
Zalcitabine—Asthenia—Ramipril—type 2 diabetes mellitus	4.24e-05	0.000211	CcSEcCtD
Zalcitabine—Pruritus—Ramipril—type 2 diabetes mellitus	4.19e-05	0.000208	CcSEcCtD
Zalcitabine—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000201	CcSEcCtD
Zalcitabine—Dizziness—Ramipril—type 2 diabetes mellitus	3.91e-05	0.000194	CcSEcCtD
Zalcitabine—Vomiting—Ramipril—type 2 diabetes mellitus	3.76e-05	0.000187	CcSEcCtD
Zalcitabine—Rash—Ramipril—type 2 diabetes mellitus	3.73e-05	0.000185	CcSEcCtD
Zalcitabine—Dermatitis—Ramipril—type 2 diabetes mellitus	3.73e-05	0.000185	CcSEcCtD
Zalcitabine—Headache—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000184	CcSEcCtD
Zalcitabine—CYP3A7—Metabolism—GNB3—type 2 diabetes mellitus	8.03e-06	0.000113	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.03e-06	0.000113	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	8.02e-06	0.000113	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HMOX1—type 2 diabetes mellitus	7.99e-06	0.000112	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	7.95e-06	0.000112	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	7.94e-06	0.000112	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CAT—type 2 diabetes mellitus	7.88e-06	0.000111	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	7.86e-06	0.000111	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	7.86e-06	0.000111	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	7.86e-06	0.000111	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	7.86e-06	0.000111	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.86e-06	0.000111	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SREBF1—type 2 diabetes mellitus	7.76e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SNAP25—type 2 diabetes mellitus	7.76e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PSMD6—type 2 diabetes mellitus	7.76e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	7.75e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	7.75e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	7.75e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	7.75e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	7.68e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	7.68e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	7.68e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	7.68e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—APOB—type 2 diabetes mellitus	7.65e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	7.62e-06	0.000107	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	7.61e-06	0.000107	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	7.55e-06	0.000106	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTM1—type 2 diabetes mellitus	7.44e-06	0.000105	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	7.43e-06	0.000104	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	7.39e-06	0.000104	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.39e-06	0.000104	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	7.36e-06	0.000104	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—LPL—type 2 diabetes mellitus	7.31e-06	0.000103	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	7.19e-06	0.000101	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	7.19e-06	0.000101	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ADCY5—type 2 diabetes mellitus	7.15e-06	0.000101	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.15e-06	0.000101	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GPX1—type 2 diabetes mellitus	7.13e-06	0.0001	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	7.1e-06	9.99e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	7.02e-06	9.88e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	7.02e-06	9.88e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.01e-06	9.86e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.01e-06	9.86e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CD36—type 2 diabetes mellitus	6.94e-06	9.77e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.93e-06	9.75e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	6.91e-06	9.71e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PPP2CA—type 2 diabetes mellitus	6.86e-06	9.65e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	6.85e-06	9.63e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	6.85e-06	9.63e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	6.73e-06	9.47e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	6.73e-06	9.47e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.68e-06	9.4e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.68e-06	9.4e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.68e-06	9.4e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	6.58e-06	9.26e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	6.45e-06	9.08e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	6.45e-06	9.07e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.41e-06	9.02e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.41e-06	9.02e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	6.39e-06	8.99e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	6.32e-06	8.89e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	6.32e-06	8.89e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	6.26e-06	8.81e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	6.26e-06	8.81e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	6.25e-06	8.79e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	6.19e-06	8.71e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.17e-06	8.68e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.17e-06	8.68e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	6.15e-06	8.66e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	6.15e-06	8.66e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	6.15e-06	8.66e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	6.15e-06	8.65e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	6.14e-06	8.64e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	6.12e-06	8.62e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	6.12e-06	8.61e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.1e-06	8.59e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	6.1e-06	8.58e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	6.1e-06	8.58e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	6.1e-06	8.58e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	6.06e-06	8.53e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.06e-06	8.53e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	6.05e-06	8.52e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	6.01e-06	8.45e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.96e-06	8.38e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.96e-06	8.38e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.96e-06	8.38e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	5.96e-06	8.38e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	5.94e-06	8.35e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	5.89e-06	8.28e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	5.8e-06	8.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.8e-06	8.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	5.77e-06	8.12e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	5.7e-06	8.02e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.6e-06	7.88e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	5.53e-06	7.78e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	5.52e-06	7.77e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	5.52e-06	7.77e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	5.52e-06	7.77e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.49e-06	7.72e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	5.47e-06	7.7e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	5.47e-06	7.7e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	5.47e-06	7.7e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.42e-06	7.62e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	5.38e-06	7.57e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	5.37e-06	7.56e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	5.37e-06	7.56e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	5.33e-06	7.51e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	5.32e-06	7.49e-05	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—AKT1—type 2 diabetes mellitus	5.32e-06	7.48e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	5.28e-06	7.43e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	5.26e-06	7.39e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.25e-06	7.39e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.24e-06	7.38e-05	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—AKT1—type 2 diabetes mellitus	5.24e-06	7.37e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	5.23e-06	7.36e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	5.21e-06	7.33e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	5.17e-06	7.27e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	5.15e-06	7.25e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.07e-06	7.13e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.07e-06	7.13e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.07e-06	7.13e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.07e-06	7.13e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.05e-06	7.1e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	5.02e-06	7.06e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.01e-06	7.04e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.99e-06	7.02e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.99e-06	7.02e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	4.96e-06	6.97e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.95e-06	6.96e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.95e-06	6.96e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.87e-06	6.85e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.86e-06	6.83e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.83e-06	6.79e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.8e-06	6.76e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	4.8e-06	6.75e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.79e-06	6.73e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.79e-06	6.73e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	4.76e-06	6.69e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	4.74e-06	6.68e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	4.74e-06	6.68e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	4.67e-06	6.56e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	4.59e-06	6.46e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	4.59e-06	6.46e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	4.52e-06	6.36e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.51e-06	6.35e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	4.44e-06	6.25e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	4.43e-06	6.23e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	4.38e-06	6.16e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.21e-06	5.93e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	4.2e-06	5.9e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.13e-06	5.81e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.13e-06	5.81e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.13e-06	5.8e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.13e-06	5.8e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.11e-06	5.78e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.09e-06	5.75e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.09e-06	5.75e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.07e-06	5.73e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.05e-06	5.7e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.05e-06	5.7e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.02e-06	5.66e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.02e-06	5.66e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.02e-06	5.66e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.02e-06	5.65e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4e-06	5.63e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.93e-06	5.53e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.93e-06	5.53e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.9e-06	5.49e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.88e-06	5.46e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3.86e-06	5.43e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.83e-06	5.38e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.79e-06	5.34e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.78e-06	5.32e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.76e-06	5.28e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.72e-06	5.24e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.68e-06	5.17e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.66e-06	5.16e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.65e-06	5.13e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.63e-06	5.11e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.61e-06	5.08e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.61e-06	5.08e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.61e-06	5.08e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.57e-06	5.02e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.54e-06	4.98e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.54e-06	4.98e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.52e-06	4.96e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.51e-06	4.94e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.49e-06	4.91e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.47e-06	4.88e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.44e-06	4.83e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.38e-06	4.76e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.35e-06	4.72e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.32e-06	4.67e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.32e-06	4.67e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.32e-06	4.67e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.3e-06	4.64e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.29e-06	4.63e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.26e-06	4.59e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.26e-06	4.59e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.21e-06	4.52e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.19e-06	4.48e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.16e-06	4.44e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.15e-06	4.43e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.13e-06	4.41e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.13e-06	4.4e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.13e-06	4.4e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.12e-06	4.39e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.11e-06	4.38e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.09e-06	4.34e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	3.03e-06	4.27e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.74e-06	3.86e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.72e-06	3.82e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.7e-06	3.79e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.7e-06	3.79e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.69e-06	3.78e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.68e-06	3.78e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.67e-06	3.75e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.65e-06	3.73e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.57e-06	3.62e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.5e-06	3.52e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.47e-06	3.47e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.46e-06	3.45e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.44e-06	3.44e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.4e-06	3.38e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.4e-06	3.37e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.36e-06	3.32e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.36e-06	3.32e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.34e-06	3.29e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.34e-06	3.29e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.33e-06	3.28e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.3e-06	3.24e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.21e-06	3.11e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.17e-06	3.05e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.16e-06	3.03e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.14e-06	3.01e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	2.11e-06	2.97e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.1e-06	2.96e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.07e-06	2.91e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.06e-06	2.9e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.03e-06	2.86e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.79e-06	2.52e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.76e-06	2.47e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.61e-06	2.27e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.54e-06	2.17e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.54e-06	2.17e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.52e-06	2.15e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.41e-06	1.98e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	1.53e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.07e-06	1.51e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.09e-07	9.97e-06	CbGpPWpGaD
